Recent Quotes
My Watchlist
Indicators
EL&P Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

iShares ESG Aware 60/40 Balanced Allocation ETF (NY:EAOR)

35.44 UNCHANGED
Streaming Delayed Price Updated: 8:00 PM EST, Jan 20, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about iShares ESG Aware 60/40 Balanced Allocation ETF

< Previous 1 2 3 Next >
VITL Shares Slip 6% On Health Concerns Around Eggs: Analyst Dismisses ‘Misleading’ Information, Reiterates ‘Buy’ Rating ↗
Via Stocktwits
News headline image
GME Stock Edges Up 3% After-Hours As CEO Increases Stake In The Retailer ↗
GameStop’s CEO Ryan Cohen disclosed an increased stake of 9.2% in the firm on Tuesday. 
Via Stocktwits
Topics Earnings
News headline image
ASTS Stock Breaks $100 Barrier — Retail Calls It A ‘Generational Instance And Communication Revolution’ ↗
Shares of AST SpaceMobile rose over 6.3% to close at $101.25 on Thursday. 
Via Stocktwits
News headline image
TGTX Rallies 7% After Hours On Revenue Estimates Based On Strong Briumvi Demand Through 2026 ↗
The company expects total revenue for full year 2025 to be about $616 million, including $594 million from sales of its Briumvi in the U.S. 
Via Stocktwits
Topics Artificial Intelligence
SRPT Stock Tumbles 12% On Lackluster Preliminary Revenue Numbers Due To Elevidys Safety Concerns ↗
Via Stocktwits
AST SpaceMobile Has Rallied 120% In Past 6 Months, Retail Still Seeing Upside Potential ↗
Via Stocktwits
RYTM Stock Jumps 4% On Imcivree Revenue Growth: Firm Awaits Approval In Acquired Hypothalamic Obesity By March ↗
Via Stocktwits
MannKind Rallies On Optimism Of Two Imminent Product Launches: Analyst Sees ‘Multiple Headwinds’ For Stock In 2026 ↗
Via Stocktwits
Zeta Global Shares Rose After It Deepens Collaboration with OpenAI ↗
Via Stocktwits
News headline image
KalVista Pharmaceuticals Stock Rallies After Hours On Strong Genetic Disorder Drug Sales Kickstart ↗
Ekterly is the first and only oral on-demand treatment for HAE, KalVista said, setting it apart from other on-demand HAE treatment options approved in the U.S. 
Via Stocktwits
News headline image
ACHR Stock Gained 5% Today – Why Investors Are Enthusiastic About Its Partnership With NVIDIA? ↗
Archer will integrate NVIDIA’s IGX Thor platform into future versions of its Midnight electric air taxi. 
Via Stocktwits
Topics Artificial Intelligence
News headline image
ELVN Stock Shot Up 60% Today – What’s Driving The Rally? ↗
The company reported positive initial data from its ongoing Phase 1b clinical trial evaluating ELVN-001 in patients with chronic myeloid leukemia. 
Via Stocktwits
News headline image
Applied Digital Posts 250% Jump In Its Quarterly Revenue ↗
Applied Digital’s HPC hosting business contributed $85 million. Its data center hosting contributed $41.6 million, up 15% year-over-year. 
Via Stocktwits
Arrowhead Pharmaceuticals Stock Jumps 22% After Morgan Stanley Hikes Price Target ↗
Via Stocktwits
Why Did INSP Stock Soar 29% Today? ↗
Via Stocktwits
AVXL Stock Draws Retail Attention Ahead Of Company’s Meeting With EMA Committee ↗
Via Stocktwits
News headline image
Joby Inks $61.5 Million Deal To Acquire Another Ready-To-Use Facility In Ohio As It Eyes Doubling eVTOL Production ↗
The new facility spans more than 700,000 feet and is ready for immediate use, the California-based company said. 
Via Stocktwits
News headline image
WULF Stock Rises 3% Pre-Market After Keefe More Than Doubles Price Target ↗
Keefe Bruyette upgraded TeraWulf to an ‘Outperform’ rating from ‘Market Perform’, citing its optimism on the company’s high-performance computing transition. 
Via Stocktwits
News headline image
Why Did RARE Stock Plunge Over 41% Today? ↗
Ultragenyx Pharmaceutical announced disappointing results from its Phase 3 studies for the setrusumab (UX143) in the Osteogenesis Imperfecta (OI) program. 
Via Stocktwits
News headline image
Biohaven Stock Slumps After Hours As Failed Depression Study Adds To A Brutal 2025 — Retail Eyes Epilepsy And Obesity Catalysts ↗
The company said that no reduction in depressive symptoms were observed in the BHV-7000 trial over six weeks as compared with placebo. 
Via Stocktwits
News headline image
Instacart Pulls Plug On AI-Driven Grocery Pricing Tests After Shopper Backlash And Regulatory Scrutiny ↗
The company said that retailers will no longer be able to use Eversight technology to run item price tests on Instacart. 
Via Stocktwits
News headline image
CACI International To Acquire ARKA From Blackstone Funds In $2.6B Cash Deal ↗
ARKA Group offers space-based sensor technology and optical technology that will enable CACI to expand its offerings 
Via Stocktwits
Topics Artificial Intelligence Government
News headline image
Disc Medicine Stock Slides After FDA Fast-Track Approval Doubts Surface — Wall Street Calls It An ‘Overreaction’ ↗
Stat News on Friday raised concerns for Biopertin’s expedited approval under the FDA Commissioner's National Priority Voucher program. 
Via Stocktwits
News headline image
Anavex Stock Slides After Hours On EMA Panel’s Negative Alzheimer’s Drug Opinion — Retail Traders Talk Buyout Potential ↗
Anavex said on Friday that the CHMP has indeed adopted a negative opinion “as expected.” 
Via Stocktwits
News headline image
Why Is SRPT Stock Falling Today? ↗
Sarepta Therapeutics announced a debt refinancing plan totaling about $291 million. 
Via Stocktwits
News headline image
Rocket Lab Is Finally Having Its SpaceX Moment — Yet One Grounded Project Could Make Or Break This Year’s Fantastic Surge ↗
When compared to the first quarter of 2021, Rocket Lab’s recent quarter reported a revenue surge of 750%, making the third quarter of this year its best one ever. 
Via Stocktwits
News headline image
SAIC Stock Surges Post Upbeat Q3 Earnings, Improved Guidance ↗
The defense and tech company’s adjusted earnings per share of $2.58 beat analyst estimates by over $0.50. 
Via Stocktwits
News headline image
AVXL Stock Jumps On Lower Q4 Loss, Anticipation For EMA Approval Of Alzheimer’s Drug ↗
Anavex ended the quarter with cash and cash equivalents of $102.6 million. 
Via Stocktwits
Topics Artificial Intelligence
News headline image
BBWI Stock Cracks Pre-Market After CEO Warns Of Softer Q3, Slashes Full-Year Guidance ↗
The company said it was revising its full-year 2025 net sales guidance to a decline in the low single digits, compared with the previous forecast of 1.5% to 2.7% growth. 
Via Stocktwits
News headline image
Joby Aviation To Launch Electric Air Taxi Test Flights In Saudi Arabia ↗
The company said that under the agreement, Joby will work together with Red Sea Global and The Helicopter Company to establish a "sandbox" for pre-commercial operations. 
Via Stocktwits
Topics Artificial Intelligence
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.